The technological ability to make personal measurements of toxicant exposures is growing rapidly. While this can decrease measurement error and therefore help reduce attenuation of effect estimates, we argue that as measures of exposure or dose become more personal, threats to validity of study findings can increase in ways that more proxy measures may avoid. We use directed acyclic graphs (DAGs) to describe conditions where confounding is introduced by use of more personal measures of exposure and avoided via more proxy measures of personal exposure or target tissue dose. As exposure or dose estimates are more removed from the individual, they become less susceptible to biases from confounding by personal factors that can often be hard to control, such as personal behaviors. Similarly, more proxy exposure estimates are less susceptible to reverse causation. We provide examples from the literature where adjustment for personal factors in analyses that use more proxy exposure estimates have little effect on study results. In conclusion, increased personalized exposure assessment has important advantages for measurement accuracy, but it can increase the possibility of biases from personal factors and reverse causation compared with more proxy exposure estimates. Understanding the relation between more and less proxy exposures, and variables that could introduce confounding are critical components to study design. (Epidemiology 2017;28: 635-643) T he capability of measuring an individual's toxicant burden is increasing at a rapid pace with decreasing cost, for example, technologies to measure an individual's breathing zone air pollution, 1 semivolatile organic compounds on silicone wrist bands, 2,3 and biomarkers of exposure in smaller amounts of biosample (e.g., blood, urine). 4 This trend will continue to lead to an explosion of environmental epidemiology research using these approaches as markers of exposure. It is clear why: these measures can provide accurate assessments of an individual's exposure to a given toxicant. In contrast, more proxy exposure estimates (i.e., further removed from the exposure of interest for the question being asked) can have a large amount of error in estimating an individual's actual exposure. Ideally the exposure of interest would be measured as precisely as possible, variables identified that can potentially introduce bias and those measured as precisely as possible, and then the appropriately adjusted analyses conducted. In practice, however, this ideal is often not possible. One issue is the choice of exposure metric to use, which can influence effect estimates in the absence of confounding, and can also affect what variables can introduce confounding. We argue here that while using more proxy exposure estimates has drawbacks, such exposure metrics can potentially provide some important advantages for causal inference in epidemiologic studies.
T he capability of measuring an individual's toxicant burden is increasing at a rapid pace with decreasing cost, for example, technologies to measure an individual's breathing zone air pollution, 1 semivolatile organic compounds on silicone wrist bands, 2, 3 and biomarkers of exposure in smaller amounts of biosample (e.g., blood, urine). 4 This trend will continue to lead to an explosion of environmental epidemiology research using these approaches as markers of exposure. It is clear why: these measures can provide accurate assessments of an individual's exposure to a given toxicant. In contrast, more proxy exposure estimates (i.e., further removed from the exposure of interest for the question being asked) can have a large amount of error in estimating an individual's actual exposure. Ideally the exposure of interest would be measured as precisely as possible, variables identified that can potentially introduce bias and those measured as precisely as possible, and then the appropriately adjusted analyses conducted. In practice, however, this ideal is often not possible. One issue is the choice of exposure metric to use, which can influence effect estimates in the absence of confounding, and can also affect what variables can introduce confounding. We argue here that while using more proxy exposure estimates has drawbacks, such exposure metrics can potentially provide some important advantages for causal inference in epidemiologic studies.
PROXY EXPOSURE MEASURES AND MEASUREMENT ERROR
From a toxicologist's perspective, if there is a question about whether a given toxicant has an adverse health effect as a result of an action on a certain tissue type, then he/she designs studies to expose that tissue to different concentrations of the toxicant and examines the resulting biologic effects. An environmental epidemiologist wanting to know the biologic effect of the toxicant on the health outcome in a study of humans may ideally want to know the target tissue dose-for example, if the outcome is liver cancer, then the toxicant concentration in the liver. (Measuring this during the appropriate time window is also critical, but for the purposes of this article, we will ignore this aspect-except as it relates to reverse causation as discussed below-because it applies to all exposure estimation approaches.) However, in an environmental epidemiology study this is often unknowable. Indeed, even external exposure is typically estimated. Thus, any measure the environmental epidemiologist uses would be a proxy for the target tissue dose, introducing measurement error. Proxy measures are those that estimate toxicant levels at stages more distal to the individual-represented by the boxes to the left of the target tissue dose box in Figure 1 -a version of the standard exposure-disease pathway model. Environmental health scientists often try to examine the entire chain of causation illustrated in Figure 1 as improved understanding of that chain can assist the design of both epidemiologic studies and public health actions. But it is important to note that determining whether a specific intervention causally affects a disease may not depend on the target tissue dose, although the latter can help in understanding the results. For example, suppose the question of interest is whether reducing average ambient air concentrations of a toxicant has an effect on a health outcome of individuals. As an extreme example, suppose this was studied in a population where everyone stayed indoors and buildings possessed filters that prevented personal exposure to the ambient toxicant. The valid answer to this question is that reducing ambient concentration has no effect here (even if in unprotected populations the answer were different). Measurement of personal exposure (or, if possible, target tissue dose) would help in understanding this result. This is similar to the toxicologic issue of understanding differences between the results of whole animal and in vitro studies. A compound that is neurotoxic in an in vitro study may show no effect in an in vivo study because the compound is not absorbed or is eliminated by a first pass effect in the liver (when administered orally) or cannot cross the bloodbrain barrier. Nevertheless, both causal questions are valid.
Alternatively, suppose that the question is defined as whether personal exposure to air pollution affects the health of an individual. In this case, the error in using ambient monitorbased exposure assessment as a proxy to estimate individual exposures is a concern. Our intent in this article is to focus on situations where personal exposure or target tissue dose are of interest. Causal questions about target tissue dose also raise issues about what constitutes "well-defined interventions," 5, 6 which we do not have space here to discuss in detail. However, while directly changing the concentrations of a toxicant at a target tissue may be difficult outside of a laboratory, it can be conceptualized as an epidemiologic intervention. In addition, the arguments we put forward here also apply if we only consider exposure measures starting at the level of external personal exposure.
A measure of absorbed dose-for example, a biomarker like toxicant concentration in blood-is often as close as an epidemiologist can get to the target tissue dose and can be a good proxy for it. In general, we expect that proxy measures more removed from the target tissue dose will have more measurement error relative to the target tissue dose. For example, polybrominated diphenyl ethers (PBDEs) are flame-retardants commonly found in indoor dust. We could measure PBDE concentrations in a study participant's serum (absorbed dose). Or we could measure PBDEs more distally, such as amounts in handwipes collected from a participant's hands (personal exposure) or amounts in dust samples from the participant's living room (microenvironment). As an estimate of PBDE concentration at a target tissue, these latter options are further removed than serum concentration and thus have more measurement error relative to the target tissue dose because of differences between people in how house dust comes into contact with the participant, and in how what reaches the participant gets into the blood. Similarly, a personal air monitor on a study participant (personal exposure) will be a more accurate exposure estimate for that person's air pollutant exposures than will air sampling from their bedroom (microenvironment) or predictions of ambient concentrations at the person's residence based on concentrations at the nearest ambient monitor to their residence or a spatiotemporal model (media). We know people do not spend all their time at home: the more time spent away from home, the less well the residential ambient pollution prediction will reflect the individual's true personal exposure. The amount of time any individual spends indoors versus outdoors at home may vary and outdoor air pollutant concentrations do not perfectly predict indoor concentrations.
The effects of exposure measurement error on effect estimates differ depending on the specific error structure, and understanding error structures is an important research question. For nondifferential measurement error, the main types of structure are Berksonian and classical, or slight variations/ mixtures of those. Berksonian error will decrease the precision of an estimate, but will not (on its own) bias the effect estimate. Classical error, in contrast, is expected to bias the effect estimate toward the null, which is a primary concern about measurement error-one that pervades environmental epidemiology. (There are notable exceptions of other error structures for which nondifferential measurement error can bias away from the null, e.g., 7-10). In fact, because of this, it has been noted in the occupational literature that there are times when group measures may have advantages over individual measures because the error structure tends more towards Berksonian than classical. 11, 12 A similar phenomenon may occur when using more smoothed area air pollution measures. While there are methods to mitigate bias toward the null, 13 under ideal circumstances, a more personal exposure measurement would be preferred because a more accurate target tissue dose representation implies a stronger and more accurate effect estimate. [14] [15] [16] [17] The problem lies in the fact that circumstances are often far from ideal.
It is important to note that in what follows we are not discussing purely ecologic studies where all variables-outcome, exposure, confounders, effect measure modifiers-are measured at the group level. Rather we mean individual-level studies that use exposure measures that are more (or less) removed from the individual target tissue dose.
CONFOUNDING BIAS
Exposure measurement error in environmental epidemiology studies, and attendant bias to the null, is an important concern, but it is not the only one. At least as important, and in some cases more so, is the concern of confounding bias. The starkest description of ideal circumstances with respect to this is one in which individual exposure is randomized, as in clinical drug trials. In environmental health this is rarely, if ever, possible. Therefore, one has to consider, for example in the case of absorbed dose, how the toxicant came to be at the concentration measured in the blood. This is dependent on individual characteristics such as toxicant pharmacokinetics and, of course, the level of the individual's exposure to the toxicant in the environment, but that may depend on behaviors of the individual. These factors (covariates) then can introduce confounding if they are related to the health outcome (other than through the exposure of interest) as illustrated in the directed acyclic graph (DAG) 5, 18, 19 of Figure 2 . Although one can try to control for such confounding, this can be a difficult task and in any epidemiology study the specter of residual or unmeasured confounding is very hard to avoid. We argue that while estimating the target tissue dose with measures that are more removed from the individual increases the error in estimating that target tissue dose, it may have the important advantage of decreasing sources of potential confounding bias that otherwise may be difficult to control. This potential tradeoff needs to be carefully considered.
POTENTIAL EPIDEMIOLOGIC ADVANTAGES OF PROXY MEASURES
To illustrate the potential advantages of more proxy exposure estimates consider the case of ambient air pollution.
A large literature on the relation between aspects of ambient air pollution and different health outcomes exists that relies on estimates of exposure derived from area air monitors or satellite imaging. [20] [21] [22] [23] For example, investigators use concentrations at the closest monitor (or some weighted average) to an individual's residence, or spatiotemporal models that incorporate monitor data and spatially and temporally varying factors-for example, traffic patterns, meteorological factors, land use characteristics-to predict outdoor ambient pollutant concentrations at the individual's residence in a given time window. These methods have been used to examine the effects of air pollution on many different health outcomes including cardiovascular, 24 respiratory, [25] [26] [27] and neurological effects, 28, 29 as well as overall mortality.
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The DAG of Figure 3A depicts a structure that assumes that the effect of exposure to ambient air pollution goes through personal exposure. In this way, the ambient air pollution prediction is a proxy measure for personal air pollution exposure and target tissue dose. Note that personal behavior differences affect personal exposure assessments directly, but they do not affect the ambient concentration prediction. In the DAG of Figure 3A , personal behavior differences (one could add personal biological characteristics like genetics here as well-either pointing into personal exposure or target tissue dose) introduce confounding to the association between personal exposure and the outcome (note that the direct arrow from personal behavior to outcome could be replaced with other statistical paths connecting the two), but not to the association between the ambient concentration prediction and the health outcome. 5 In fact, in the DAG of Figure 3A as drawn, the ambient concentration prediction is an instrumental variable (IV) for personal pollutant exposure, because it fulfills the three conditions for an IV 33, 34 : (i) ambient concentration prediction is associated with personal air pollutant exposure, (ii) ambient concentration prediction does not cause the outcome except through personal air pollutant exposure, and (iii) ambient concentration prediction does not share any causes with the outcome. As such, the ambient concentration prediction avoids confounding by measured or unmeasured (even unknown) variables like the personal behaviors indicated in the figure that confound the personal exposure-health outcome association. 33, 34 The DAG of Figure 3A , however, is clearly over-simplified. It is possible that there could be confounding of the association between the ambient concentration prediction and the outcome by other variables (L; Figure 3B ), violating the third requirement of an IV (note that if all possible L could be fully controlled, then the ambient concentration prediction could still be an IV conditional on controlling those L variables). These L variables should be predictors of ambient air pollution like socioeconomic status (SES; potentially both individual and area), urbanicity, population density, and meteorological variables. [35] [36] [37] [38] [39] SES factors can affect where a person lives, which can be related to many health outcomes; urbanicity and population density could be related to case ascertainment issues; and meteorological factors at least in some cases could be related to health outcomes. 40, 41 However, these L variables also introduce confounding to the personal exposure-outcome association ( Figure 3B) . Thus, the set of possible confounding variables for the ambient concentration estimation cannot be larger than that for personal exposure. The magnitude of, and ability to control confounding by L of the ambient estimate versus confounding of the personal exposure estimate by personal behavior and L is hard to gauge and needs to be evaluated in any study setting. However, in the case of ambient air pollution, and perhaps in other exposure model settings, we hypothesize that the predictors of the proxy exposure estimate may be better understood and controlled than individual behavioral predictors of personal exposure. (However, one potential problem is that group-level exposure variables have the potential to introduce aspects of ecologic bias, even in otherwise individuallevel studies 7, 42, 43 ). Similarly, physiologic factors may sometimes confound associations between biomarkers of exposure and health outcomes. For example, it has been suggested that much of the association between maternal or cord plasma perfluoroalkyl substances (PFAS) and birthweight can be explained by confounding by glomerular filtration rate (GFR) 44 -that is, that differences in GFR and the size of the developing fetus (and eventually birthweight) are both related to some maternal factors. Thus, because differences in GFR affect the concentration of plasma PFAS, the PFAS-birthweight association is confounded as illustrated in Figure 4 . In some settings, it is possible to develop models of external exposures to PFAS, for example, using data on contamination of drinking water sources in the mid-Ohio valley region. 45 Using such a model of external PFAS exposures as a proxy for plasma PFAS would avoid the confounding from maternal factors that affect GFR (as well as confounding by personal behavior differences as described above; Figure 4 ). While one could avoid this by using prepregnancy samples or controlling GFR, these data can be hard to get and in some studies, for example, of insidious onset diseases, one may not know when "before" the disease is.
This general concept of the use of more proxy exposure estimates to avoid confounding in analyses of less proxy measures is precisely why one does intention-to-treat analyses in randomized control trials. 5 Assignment to a drug treatment arm is a more proxy exposure estimate than is actual medications taken or internal dose of the medication because not all people assigned to the drug take it as the investigators intend (and possibly those in the control arm could get access to the drug by other means). While using the actual medications taken or a measure of internal dose would provide a more accurate indication of the exposure to the drug, analyses with those exposures would be subject to confounding by all the factors that predict whether the drug is taken and how it is absorbed. A similar concept of using more proxy exposure measures as IVs for personal exposure has been discussed in the occupational literature. For example, it has been pointed out that if individual personal exposure measurements are made among workers in a particular group (e.g., those in a particular job), then the average of the individual measures, under some conditions, can act like an IV for individual-level exposure. 46 The reason this approach only works under some conditions is that the group average exposure violates one of the three requirements for an IV. If the more proxy exposure estimate is based on averages of individual exposure measures, then the variables that cause confounding of the individual exposure measure-outcome association can also introduce confounding of the group average-outcome association, violating the third condition for an IV listed above. In this case, the advantage of using the more proxy exposure estimate is diminished, as it would also require control of the variables that could confound the more personal exposure measure, although the degree to which the IV condition is violated diminishes with larger group sizes. 46 This is not a problem if individual characteristics do not influence the more proxy estimate, as in our example of ambient air pollution predictions. A slightly different issue, but one that shares some similarities, is how under some conditions gene-only models often more reliably indicate the presence-if not precise magnitude-of a gene-environment interaction than a model with an environmental exposure and gene-by-environment interaction term, in part because only including the gene term avoids potential confounding bias from variables that confound the environmental exposure-outcome association. 47, 48 
EXAMPLES
If more proxy exposure estimates avoid confounding from personal factors that affect personal exposure (or target tissue dose) measures, then effect estimates for those more proxy measures should not be affected by adjustment for the personal factors, although even in the complete absence of confounding some small change will likely be present just from statistical fluctuation. The examples in the Table are consistent with our argument that more proxy measures are less susceptible to confounding by personal factors, but they cannot prove that. If the personal factor does not confound the association with the personal exposure (or target tissue dose) measure (perhaps because it is not related to the personal exposure or because adjustment for other factors sufficiently adjusts for the personal factor in question), then showing that it does not confound a more proxy measure does not inform our argument. In the traffic pollution study in the Table  49 we assume, for example, that playing sports could affect personal traffic pollution exposure (perhaps related to location) as well as atrial fibrillation (through exercise), and thus confound the association with personal exposure. If so, the lack of change in the effect estimate for the model-based traffic pollution estimate argues for our point, but not if the confounding at the personal level is minimal (maybe because there was not an association between playing sports and traffic pollution exposure). To empirically address our hypothesis, what is needed are studies that estimate exposure with both a more proxy and a personal exposure measure and collect data on a personal variable that introduces confounding of the personal exposure measure-outcome association.
REVERSE CAUSATION
An additional benefit of less-individual based exposure estimates is that they can avoid biases from reverse causation. In many cases, use of a biosample to assess personal exposure to a contaminant can be compromised by unrecognized effects of the outcome (or antecedents of the outcome) on the measurement of the toxicant in the biosample. An interesting potential case of reverse causation is PBDEs and hyperthyroidism in cats. Prevalence of feline hyperthyroidism has increased over the past several decades, making it a common disease of older cats. 54 Risk factors include certain kinds of diet and living indoors; endocrine disruption by environmental chemicals, such as PBDEs, has also been hypothesized. Cats have higher levels of PBDEs than humans, potentially due to grooming behavior (e.g., 55) because PBDEs are found in house dust. PBDEs have been associated with altered thyroid hormone levels in both laboratory animals and humans (e.g., 56, 57). Of six small cross-sectional studies of PBDEs and feline hyperthyroidism, two reported associations between PBDE concentrations in blood (on a lipid weight basis) and hyperthyroidism. 55, [58] [59] [60] [61] [62] However, feline hyperthyroidism causes substantial weight loss. As PBDEs are lipophilic, weight loss will tend to increase concentrations of such compounds in body lipids, including blood lipid. Indeed, a few studies report elevated concentrations of other lipophilic compounds. Thus the reported associations may be at least partly due to reverse causation ( Figure 5) . 58 Use of dust as a proxy exposure measure has the potential of mitigating the reverse causation because if reverse causation accounts for the The results we are reporting in the table are not in the original article, but were provided to us by Hart et al. 16 after she analyzed the data in a model with a slightly different set of covariates.
a Similar lack of change of effect estimates seen after adjustment for many other personal factors was also reported, but data not shown; this has also been noted by this group in other studies of theirs as well.
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The results we are reporting in the table are not in the original paper, but were provided to us by Dr. Hart after she analyzed the data in a model with a slightly different set of covariates. CO indicates carbon monoxide; HR, hazard ratio; IRR, incidence rate ratio; NO 2 , nitrogen dioxide; OR, odds ratio; PCE, tetrachloroethylene; PM 2.5 , particulate matter <2.5 μm in diameter.
association between blood PBDE and feline hyperthyroidism, then no association between dust concentrations and hyperthyroidism would be seen ( Figure 5 ).
CONCLUSIONS
In summary, there may often be a tradeoff between exposure measurement error and potential confounding as exposure estimates are more removed from the individual. Personal behaviors and individual physiologic factors can confound associations between biosample measures and health outcomes; an individual's metabolism should not confound microenvironment measurement-outcome associations, but individual behaviors could (although likely less than with a biomarker); neither should confound associations with estimates based on sources and emissions or larger scale media. We hypothesize that the factors introducing confounding to an association with a more proxy exposure estimate are often fewer and more easily identifiable than those that could do so for an association with a personal exposure measurement. When using a more proxy exposure estimate, personal behaviors or preclinical aspects of the outcome under study are not a concern because actual personal exposure is a collider between the more proxy estimate and factors that cause confounding or reverse causation of personal exposure-outcome associations. Factors that can confound a personal exposure-outcome association can often be extremely hard to completely identify, let alone condition out analytically. Furthermore, while some variables could still introduce confounding to an association with a more proxy exposure estimate, for example SES factors, these variables would still be of concern in an analysis with a personal exposure measure. It is also important to note that for relatively time-invariant covariates like SES factors, if specific time windows of exposure for associations with an outcome are found, this can rule out confounding by time-invariant variables based on negative control exposures principles. 29, [63] [64] [65] Although there are methods that have been proposed to account for unmeasured confounding, [66] [67] [68] they necessarily make assumptions about the structure of the unmeasured (possibly unknown) confounding. Thus, the possibility of simply eliminating some possible confounding may sometimes be preferable.
The critical aspect of a more proxy exposure estimate that allows its use to avoid much confounding and reverse causation that can affect more personal exposure measurements is that the factors used in creating the exposure estimate, and the distribution of the exposure in the environment, are unrelated to individual behaviors or characteristics of those in the study population. It is, however, critical that the exposure estimate be reasonably good or bias to the null from exposure misclassification could be so pronounced as to obscure true associations. An association with a more proxy measure is likely to be biased to the null compared with the true personal exposureoutcome association. So while the proxy may effectively indicate the presence of a personal exposure-outcome association, it likely does not accurately reflect its magnitude. Thus, studies to understand how well a proxy exposure estimate predicts actual personal exposures are critical. With such data one can use established methods to correct for bias to the null from measurement error. 12, 13, 69, 70 The fact that this can be done is another argument for using more proxy exposure estimates: the drawback of bias to the null from exposure measurement error may be more easily addressed than the drawback with more personal exposure measures of needing to control for additional confounding or reverse causation biases that may not even be recognized. Furthermore, with the more proxy exposure estimate there is the possibility of using the correlation with more personal exposure in IV analyses. 29, 30 In addition, in many settings, it is not feasible to make individual measurements on everyone.
We believe that more research is needed into the degree of bias to the null with measurement error in different settings and on the degree of confounding introduced by personal exposure measures. Comparisons of the magnitude of these two effects would be a useful line of research. However, the potential value of more proxy exposure estimates to avoid important sources of confounding-even some of which we are unaware-should not be overlooked when deciding how to handle exposure assessment for a study.
